GlassScriptPhysician profile
Srikanth A Reddy
NPI 1649440744
$36,358.14
in general payments reported to CMS, 2019-2025
100 companies · $7,404 in 2025
The $7,404 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,238 · 2020: $1,725 · 2021: $3,245 · 2022: $4,002 · 2023: $5,369 · 2024: $6,375 · 2025: $7,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Consulting Fee: $4,150 · Education: $399 · Travel and Lodging: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,347.96 |
| Consulting Fee | $4,150.00 |
| Education | $398.93 |
| Travel and Lodging | $250.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,929.18 | 2020-2025 | |
| Mckesson Specialty Care Distribution, LLC | $4,690.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $2,357.13 | 2019-2025 | Enhertu, Calquence, Tagrisso |
| Janssen Biotech, INC. | $2,141.97 | 2019-2025 | Carvykti, Rybrevant, Darzalex |
| E.R. Squibb & Sons, L.L.C. | $1,593.92 | 2019-2025 | Opdivo |
| Pfizer INC. | $1,592.20 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,409.51 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $1,370.43 | 2019-2025 | |
| Celgene Corporation | $987.27 | 2019-2025 | Reblozyl, Pomalyst, Opdivo |
| Astellas Pharma US INC | $967.92 | 2019-2025 | Xospata, Veozah, Vyloy |
| Amgen INC. | $908.03 | 2019-2023 | Kyprolis, Blincyto, Evenity |
| Seagen INC. | $877.21 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Takeda Pharmaceuticals U.S.A., INC. | $851.49 | 2019-2025 | Iclusig, Ninlaro, Fruzaqla |
| Glaxosmithkline, LLC. | $761.01 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Pharmacyclics LLC, An Abbvie Company | $758.89 | 2019-2023 | Imbruvica, Epkinly |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $589.04 | 2019-2025 | Enhertu, Injectafer |
| Lilly USA, LLC | $564.67 | 2019-2025 | Verzenio, Jaypirca |
| Eisai INC. | $448.07 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $445.60 | 2023-2025 | Libtayo |
| Genzyme Corporation | $422.05 | 2021-2025 | |
| Genentech USA, INC. | $394.82 | 2019-2025 | Tecentriq, Alecensa, Polivy |
| Kite Pharma, INC. | $357.80 | 2019-2025 | Yescarta |
| Adc Therapeutics America, INC. | $324.11 | 2022-2025 | |
| Array Biopharma INC | $317.51 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Bayer Healthcare Pharmaceuticals INC. | $297.76 | 2019-2025 | |
| Puma Biotechnology, INC. | $274.46 | 2019-2023 | |
| Incyte Corporation | $251.14 | 2019-2025 | Jakafi, Niktimvo |
| Jazz Pharmaceuticals INC. | $247.84 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $205.50 | 2020-2025 | Xpovio |
| Coherus Oncology, INC. | $189.29 | 2020-2025 | Loqtorzi |
| Gilead Sciences, INC. | $189.20 | 2019-2025 | Trodelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $183.73 | 2019-2023 | Gilotrif |
| Reflexion Medical, INC. | $175.00 | 2022 | |
| Beigene USA, INC. | $161.56 | 2021-2025 | Brukinsa |
| Pharmacosmos Therapeutics INC. | $161.17 | 2023-2025 | Monoferric |
| Springworks Therapeutics, INC. | $159.55 | 2024-2025 | Ogsiveo |
| Ethicon INC. | $158.57 | 2022 | |
| Geron Corporation | $158.56 | 2024-2025 | Rytelo |
| Myovant Sciences INC. | $155.95 | 2021-2022 | |
| Sirtex Medical INC | $148.50 | 2019 | |
| Emd Serono, INC. | $145.94 | 2021-2025 | Bavencio |
| Tactile Systems Technology INC | $136.45 | 2023 | Flexitouch Plus, Entre Plus |
| Stemline Therapeutics INC. | $133.66 | 2019-2025 | Orserdu |
| US Oncology Corporate, INC. | $126.48 | 2024 | |
| Rigel Pharmaceuticals, INC. | $125.05 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Pharmaessentia USA Corporation | $114.57 | 2022-2025 | Besremi |
| Progenics Pharmaceuticals, INC. | $106.84 | 2024 | |
| Cti Biopharma Corp. | $105.32 | 2022-2023 | Vonjo |
| Alexion Pharmaceuticals, INC. | $98.87 | 2019-2024 | Ultomiris |
| Clovis Oncology, INC. | $98.82 | 2019-2022 | |
| Acrotech Biopharma INC. | $95.74 | 2021-2022 | |
| Taiho Oncology, INC. | $93.26 | 2019-2024 | |
| Sobi, INC | $87.81 | 2022-2023 | |
| Kyowa Kirin, INC. | $87.79 | 2019-2025 | Poteligeo, Crysvita |
| Genmab U.S., INC. | $85.23 | 2024-2025 | Epkinly |
| Aveo Pharmaceuticals, INC. | $83.03 | 2024-2025 | |
| Octapharma USA, INC. | $70.06 | 2023 | Panzyga, Octagam Immune Globulin (Human) |
| Tempus Ai, INC | $65.85 | 2025 | Xt Cdx |
| Secura Bio, INC. | $59.17 | 2023-2025 | Copiktra |
| Agios Pharmaceuticals, INC. | $58.84 | 2024-2025 | Pyrukynd |
| Foundation Medicine, INC. | $57.72 | 2023 | |
| Recordati_rare_diseases_inc. | $53.43 | 2024-2025 | Enjaymo, Sylvant |
| Legend Biotech USA INC. | $53.40 | 2025 | Carvykti |
| Ipsen Biopharmaceuticals, INC | $52.05 | 2020-2021 | |
| Spectrum Pharmaceuticals INC. | $50.98 | 2024-2025 | Rolvedon |
| Tesaro, INC. | $49.05 | 2019 | |
| Beone Medicines USA, INC. | $48.58 | 2025 | Brukinsa |
| Morphosys, US INC. | $45.38 | 2022-2023 | Monjuvi |
| Azurity Pharmaceuticals, INC. | $39.26 | 2024-2025 | Vivimusta |
| Global Blood Therapeutics, INC. | $38.77 | 2021-2022 | |
| Tersera Therapeutics LLC | $38.21 | 2023 | Zoladex |
| Dova Pharmaceuticals | $36.26 | 2020 | |
| Blueprint Medicines Corporation | $33.87 | 2023 | Ayvakit |
| Apo-Pharma USA, INC. | $33.64 | 2019 | |
| Dendreon Pharmaceuticals LLC | $33.28 | 2022 | |
| Insulet Corporation | $30.37 | 2019 | |
| Dexcom, INC. | $28.75 | 2022-2024 | Dexcom G6 Transmitter |
| Mylan Institutional INC. | $27.95 | 2022 | |
| Deciphera Pharmaceuticals INC. | $27.89 | 2024 | Qinlock |
| Lexicon Pharmaceuticals, INC. | $27.50 | 2019 | |
| Novocure INC. | $26.78 | 2025 | Optune Lua (Novottf-200t) |
| Fennec Pharmaceuticals, INC. | $25.08 | 2025 | Fyarro |
| Sun Pharmaceutical Industries INC. | $24.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.53 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $23.89 | 2023 | Avastin, Neupogen, Neulasta |
| Biocompatibles, INC. | $22.88 | 2019 | |
| Ferring Pharmaceuticals INC. | $22.55 | 2019 | |
| Servier Pharmaceuticals LLC | $21.28 | 2024 | |
| Sanofi US Services INC. | $20.29 | 2025 | |
| Cardinal Health 414 LLC | $20.14 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Verity Pharmaceuticals INC. | $19.91 | 2025 | Trelstar |
| G1 Therapeutics, INC. | $19.61 | 2022 | |
| Myriad Genetic Laboratories, INC. | $18.09 | 2023 | Precisetumor |
| Amag Pharmaceuticals, INC. | $17.87 | 2021 | |
| Syndax Pharmaceuticals, INC. | $16.61 | 2025 | |
| Caris Mpi, INC. | $16.35 | 2025 | Mi Cancer Seek |
| Advanced Accelerator Applications | $16.10 | 2019 | |
| Aurobindo Pharma USA, INC. | $15.51 | 2020 | |
| Novo Nordisk INC | $11.98 | 2020 | |
| West Therapeutics Development, LLC | $11.29 | 2020 |
Drugs and devices associated with these payments
Venclexta $4,599Keytruda $798Opdivo $754Enhertu $686Imbruvica $628Tukysa $582Reblozyl $510Libtayo $446Carvykti $431Epkinly $387Kisqali $380Jemperli $372Rybrevant $371Ibrance $355Darzalex $353Lynparza $343Zejula $321Calquence $305Braftovi $275Scemblix $273Tagrisso $264Mektovi $251Adcetris $200Erleada $199Imfinzi $197Zepzelca $193Lorbrena $191Sarclisa $186Brukinsa $172Iclusig $171Xospata $164Tecvayli $163Monoferric $161Xtandi $160Ogsiveo $160Padcev $159Yescarta $159Rytelo $159Verzenio $151Ninlaro $145Elrexfio $141Flexitouch Plus $136Entre Plus $136Lenvima $131Orserdu $110Pylarify $107Comirnaty $105Ojjaara $104Welireg $102Udenyca $98.55Xalkori $97.42Tecentriq $90.21Jaypirca $89.08Akeega $87.02Jakafi $86.59Inlyta $86.54Fotivda $83.03Vonjo $81.74Besremi $81.50Ayvakit $79.79Balversa $79.15Enjaymo $78.69Bosulif $77.92Gavreto $75.14Oxbryta $72.56Orgovyx $69.30Pomalyst $68.59Loqtorzi $68.10Xt Cdx $65.85Kyprolis $64.61Alecensa $64.20Doptelet $61.06Talzenna $60.63Copiktra $59.17Polivy $58.99Avastin $58.57Zynlonta $56.86Xpovio $53.14Poteligeo $52.93Tavalisse $51.92Rezlidhia $51.92Rolvedon $50.98Fruzaqla $50.67Pluvicto $50.08Lonsurf $46.71Inqovi $46.71Tasigna $46.66Veozah $45.23Blincyto $43.74Trodelvy $40.25Panzyga $40.06Vivimusta $39.26Cablivi $38.52Zoladex $38.21Bavencio $38.14Ziihera $37.07Rozlytrek $34.68Prolia $33.59Evenity $33.59Mekinist $32.42
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srikanth Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.